Cargando…
Fatty acid metabolism and drug resistance to EZH2 inhibition
Autor principal: | Wang, Yemin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897622/ https://www.ncbi.nlm.nih.gov/pubmed/35248993 http://dx.doi.org/10.1016/j.ebiom.2022.103916 |
Ejemplares similares
-
Relationship of Circulating Fatty Acid Profile to Metabolic Disorders Associated with Insulin Resistance
por: Kazdova, Ludmila
Publicado: (2015) -
Pharmacological targeting EZH2 to modulate chronic graft-versus-host disease
por: Wang, Ying
Publicado: (2022) -
2-Hydroxylated fatty acids as candidates of novel drugs to promote chemosensitivity of gastric cancer
por: Tsuboi, Kazuhito
Publicado: (2019) -
Metabolic Flexibility of Mitochondria Plays a Key Role in Balancing Glucose and Fatty Acid Metabolism in the Diabetic Heart
por: Gambardella, Jessica, et al.
Publicado: (2020) -
Targeted Disruption of the EZH2/EED Complex Inhibits EZH2-dependent Cancer
por: Kim, Woojin, et al.
Publicado: (2013)